One to Watch: China’s Cell and Gene Therapies Industry

Published on January 19, 2023

When addressing current and upcoming issues in the Asia-Pacific (APAC) pharmaceutical industry, cell and gene therapies (CGTs) should be of primary focus. It’s no surprise that a treatment market that will change the face of pharma has stakeholders rushing to invest, receiving over $70 billion of total funding last year.